Home › Pain After Surgery › NCT03230565
Continuous Infusions vs Scheduled Bolus Infusions
RecruitingPhase 4
A Prospective Comparison of Pain and Analgesia in Patients With Continuous Peripheral Nerve Block Catheters Using Continuous Infusion or Scheduled Bolus Infusion
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Adult patients presenting for nerve block catheters for post-operative analgesia * ASA physical status I, II, or III. Exclusion Criteria: * Pregnancy * Incarceration * Age \<18 * BMI \>35 * Pre-operative opioid use \>30 mg morphine equivalents per day * Inability to communicate with investigators by telephone * Pre-existing neuropathy of the operative extremity.
About the study
The goal of the study is to compare continuous infusions and scheduled bolus infusions for peripheral nerve blocks and their effect on post-surgical pain.
What is being tested
- Ropivacaine (drug)
- Ropivacaine (drug)
Sponsor: Stanford University · Participants: 240 · Started: Jun 1, 2018
Contact the study team
- Aaron J Deng, BS · Phone: 408-914-5494
Official record on ClinicalTrials.gov — NCT03230565
Locations in the U.S.
| California | Stanford University, Stanford |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.